Page last updated: 2024-08-23

vecuronium bromide and Neuromuscular Diseases

vecuronium bromide has been researched along with Neuromuscular Diseases in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (9.09)	18.7374
1990's	5 (45.45)	18.2507
2000's	3 (27.27)	29.6817
2010's	2 (18.18)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ao, L; Cao, J; Li, W; Liu, L; Luo, J; Min, S; Wang, B; Wang, Z; Wei, K; Wu, G	1
Lewald, H; Schaller, SJ	1
Murouchi, T; Ohsone, J; Yamakage, M	1
Bourke, DL; Hall, BA; Keegan, MT; Ramirez, JG; Sprung, J	1
Ramsay, DA; Zochodne, DW	1
Bernstein, D	1
Champion, H; Frankel, H; Jeng, J; St Andre, A; Tilly, E	1
Ariño, JJ; Ferreiro, N; Gómez, E; Perucho, A	1
Aymerich, H; Ferreira, TA; Molins, N; Pensado, A; Rama-Maceiras, P; Vázquez-Fidalgo, A	1
Coffiniéres, A; Huault, G; Landrieu, P; Sébire, G; Tabarki, B; Van Den Bergh, P	1
Schindler, MB	1

Reviews

3 review(s) available for vecuronium bromide and Neuromuscular Diseases

Article	Year
Clinical pharmacology and efficacy of sugammadex in the reversal of neuromuscular blockade. Expert opinion on drug metabolism & toxicology, 2016, Volume: 12, Issue:9 Topics: Androstanols; Animals; gamma-Cyclodextrins; Humans; Neuromuscular Blockade; Neuromuscular Diseases; Neuromuscular Nondepolarizing Agents; Rocuronium; Sugammadex; Vecuronium Bromide	2016
[Reversal of neuromuscular blockade and complications of remaining blocking effect]. Masui. The Japanese journal of anesthesiology, 2008, Volume: 57, Issue:7 Topics: Androstanols; Anesthesia Recovery Period; Cholinesterase Inhibitors; Clinical Trials, Phase III as Topic; gamma-Cyclodextrins; Humans; Neostigmine; Neuromuscular Blocking Agents; Neuromuscular Diseases; Pancuronium; Rocuronium; Sugammadex; Vecuronium Bromide	2008
Critical illness neuromuscular disease: clinical, electrophysiological, and prognostic aspects. Archives of disease in childhood, 2002, Volume: 86, Issue:2 Topics: Adolescent; Child; Child, Preschool; Critical Illness; Electromyography; Electrophysiology; Fatal Outcome; Female; Humans; Male; Neural Conduction; Neuromuscular Diseases; Neuromuscular Nondepolarizing Agents; Prognosis; Retrospective Studies; Vecuronium Bromide	2002

Other Studies

8 other study(ies) available for vecuronium bromide and Neuromuscular Diseases

Article	Year
Pharmacodynamic changes with vecuronium in sepsis are associated with expression of α7- and γ-nicotinic acetylcholine receptor in an experimental rat model of neuromyopathy. British journal of anaesthesia, 2014, Volume: 112, Issue:1 Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Dose-Response Relationship, Drug; Glycoproteins; Immunohistochemistry; Male; Muscle, Skeletal; Neuromuscular Diseases; Neuromuscular Nondepolarizing Agents; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Sepsis; Vecuronium Bromide; Weight Gain	2014
Neostigmine-induced prolonged neuromuscular blockade in a patient with atypical pseudocholinesterase. Journal of clinical anesthesia, 2005, Volume: 17, Issue:3 Topics: Butyrylcholinesterase; Cholinesterase Inhibitors; Cystoscopy; Humans; Male; Middle Aged; Neostigmine; Neuromuscular Blockade; Neuromuscular Blocking Agents; Neuromuscular Diseases; Polycystic Kidney Diseases; Succinylcholine; Time Factors; Vecuronium Bromide	2005
Acute quadriplegic myopathy. Neurology, 1994, Volume: 44, Issue:5 Topics: Creatine Kinase; Humans; Neuromuscular Blocking Agents; Neuromuscular Diseases; Peripheral Nervous System Diseases; Quadriplegia; Vecuronium Bromide	1994
Prolonged weakness and vecuronium. Annals of internal medicine, 1993, Apr-01, Volume: 118, Issue:7 Topics: Dose-Response Relationship, Drug; Humans; Neuromuscular Diseases; Vecuronium Bromide	1993
The impact of implementation of neuromuscular blockade monitoring standards in a surgical intensive care unit. The American surgeon, 1996, Volume: 62, Issue:6 Topics: Aged; Atracurium; Cost-Benefit Analysis; Critical Care; Drug Therapy; Electrolytes; Female; Humans; Incidence; Male; Middle Aged; Monitoring, Physiologic; Muscle Contraction; Muscle, Skeletal; Neuromuscular Diseases; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Paralysis; Prospective Studies; Rehabilitation; Respiration, Artificial; Retrospective Studies; Risk Factors; Thumb; Vecuronium Bromide	1996
[Familial spastic paraparesis. Apropos of a case]. Revista espanola de anestesiologia y reanimacion, 1995, Volume: 42, Issue:10 Topics: Aged; Genetic Predisposition to Disease; Humans; Intraoperative Complications; Male; Muscle Denervation; Muscle Relaxants, Central; Neuromuscular Diseases; Neuromuscular Nondepolarizing Agents; Prostatectomy; Vecuronium Bromide	1995
[Prolonged neuromuscular block after a single dose of vecuronium in a patient with undiagnosed polyneuropathy and steroid myopathy]. Revista espanola de anestesiologia y reanimacion, 1999, Volume: 46, Issue:1 Topics: Anesthesia Recovery Period; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Muscular Atrophy; Nervous System Diseases; Neuromuscular Diseases; Neuromuscular Nondepolarizing Agents; Postoperative Complications; Prednisone; Renal Artery Obstruction; Succinylcholine; Vecuronium Bromide	1999
Prolonged neuromuscular blockade following the use of vecuronium for mediastinoscopy. Anaesthesia and intensive care, 1989, Volume: 17, Issue:3 Topics: Aged; Female; Humans; Mediastinoscopy; Myasthenia Gravis; Neostigmine; Neuromuscular Diseases; Time Factors; Vecuronium Bromide	1989